Urogen Pharma Ltd (URGN)

Capital Expenditure

-$218.00K

TTM · Period ending: · USD

URGN logo

URGN Capital Expenditure

Latest reported-$218.00K
URGN TTM CapEx (-$695.00K → -$218.00K)
High-resolution chart · PNG

URGN capital expenditure history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Urogen Pharma Ltd Capital Expenditure — Trailing twelve months (TTM) (USD)
Period endingCapital Expenditure (USD)
-218,000
-299,000
-289,000
-387,000
-396,000
-339,000
-295,000
-233,543
-237,543
-168,543
-191,543
-151,000
-198,664
-246,664
-248,664
-437,664
-484,000
-490,000
-752,000
-722,000
-1,188,000
-1,406,000
-1,215,000
-1,235,000
-624,000
-377,000
-325,000
-157,000
-440,000
-532,000
-560,000
-689,000
-377,000
-265,000
-271,000
-235,000
-350,000
-703,000
-695,000
-646,000
-702,000
-338,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.